In this regard, oncogenic RAS, which is the most common mutation in human cancers (~19% of human cancers harbor a RAS mutation; ref. 64), has been shown to induce IL-8 expression to increase neutrophil recruitment to tumor sites (65). Here, CXCL8 is linked to cancer.